Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan - A proteomic analysis

Journal of Physiology and Biochemistry

Volumn 66, Issue 4, 2010, Pages 329-338

  Liu, Li ^a   Wang, Wen ^a   Meng, Xianmin ^a   Gao, Jiuming ^a   Wu, Haiying ^a   Wang, Peihe ^a   Wu, Weichun ^a   Wang, Linlin ^a   Ma, Liyuan ^a   Zhang, Weiguo ^b  

^a FUWAI HOSPITAL   (China)

^b Cardiovascular and Neurological Consulting Institute   (United States)

Author keywords

Abdominal aortic banding (AB); Angiotensin II receptor blocker (ARB); Blood pressure (BP); Hypertension; Left ventricular hypertrophy (LVH); Protein expression; Proteomics; Renin angiotensin system (RAS); Telmisartan

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ASPARTIC ACID TRANSFER RNA; BETA GLOBIN; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN; MYOSIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; PROTEIN KINASE ZAP 70; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MUSCLE; HEART RATE; HEART WEIGHT; HEMODYNAMICS; HYPERTENSION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; PROTEOMICS; RAT; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; AORTA; AORTA, ABDOMINAL; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS;

EID: 78650169348     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-010-0039-1     Document Type: Article

References (30)

1. G Agnetti K Bezstarosti DH Dekkers AJ Verhoeven E Giordano C Guarnieri CM Caldarera JE Van Eyk JM Lamers 2008 Proteomic profiling of endothelin 1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and alpha-B crystallin Biochim Biophys Acta 1784 1068 1076 1:CAS:528:DC%2BD1cXnt1Ciur0%3D 18472024
2. S Arab AO Gramolini P Ping T Kislinger B Stanley J van Eyk M Ouzounian DH MacLennan A Emili PP Liu 2006 Cardiovascular proteomics: tools to develop novel biomarkers and potential applications J Am Coll Cardiol 48 1733 1741 1:CAS:528:DC%2BD28XhtFOjtb7L 10.1016/j.jacc.2006.06.063 17084242 (Pubitemid 44648616)
3. M Bohm M Lee R Kreutz S Kim M Schinke B Djavidani J Wagner M Kaling W Wienen M Bader D Ganten 1995 Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin system gene expression and cardiovascular functions J Hypertens 13 891 899 1:STN:280:DyaK28%2FltVSlsA%3D%3D 10.1097/00004872- 199508000-00010 8557967
4. M Calvani E Reda E Arrigoni-Martelli 2000 Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions Basic Res Cardiol 95 75 83 1:CAS:528:DC%2BD3cXktVOnt7g%3D 10.1007/s003950050167 10826498 (Pubitemid 30251262)
5. RB Devereux 1995 Left ventricular geometry, pathophysiology and prognosis J Am Coll Cardiol 25 885 887 1:STN:280:DyaK2M7ptVWmtA%3D%3D 10.1016/0735-1097(94)00547-4 7884092
6. Z El Alaoui-Talibi A Guendouz M Moravec J Moravec 1997 Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-l-carnitine Am J Physiol 272 H1615 H1624 1:CAS:528:DyaK2sXivF2ktrc%3D 9139943
7. MJ Faber M Dalinghaus IM Lankhuizen K Bezstarosti DH Dekkers DJ Duncker WA Helbing JM Lamers 2005 Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy Proteomics 5 2519 2530 1:CAS:528:DC%2BD2MXmtF2gt7o%3D 10.1002/pmic.200401313 15912512 (Pubitemid 40966479)
8. M Goebel M Clemenz T Unger 2006 Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan Expert Rev Cardiovasc Ther 4 615 629 1:CAS:528:DC%2BD28XhtFKitL7M 10.1586/14779072.4.5.615 17081084 (Pubitemid 44739598)
9. RD Hannan A Jenkins AK Jenkins Y Brandenburger 2003 Cardiac hypertrophy: a matter of translation Clin Exp Pharmacol Physiol 30 517 527 1:CAS:528:DC%2BD3sXms1Whsbc%3D 10.1046/j.1440-1681.2003.03873.x 12890171 (Pubitemid 37011588)
10. X Jin L Xia LS Wang JZ Shi Y Zheng WL Chen L Zhang ZG Liu GQ Chen NY Fang 2006 Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats Proteomics 6 1948 1956 1:CAS:528:DC%2BD28XjtlKmt7s%3D 10.1002/pmic.200500337 16485256
11. AU Klingbeil M Schneider P Martus FH Messerli RE Schmieder 2003 A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension Am J Med 115 41 46 10.1016/S0002-9343(03)00158-X 12867233 (Pubitemid 36831120)
12. D Levy RJ Garrison DD Savage WB Kannel WP Castelli 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1561 1566 1:STN:280:DyaK3c3ksFSmug%3D%3D 10.1056/NEJM199005313222203 2139921
13. ML Lindsey DK Goshorn S Comte-Walters JW Hendrick E Hapke MR Zile K Schey 2006 A multidimensional proteomic approach to identify hypertrophy-associated proteins Proteomics 6 2225 2235 1:CAS:528:DC%2BD28Xjslyrsbc%3D 10.1002/pmic.200500013 16493702
14. BH Lorell 1999 Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease Am J Cardiol 83 48H 52H 1:CAS:528:DyaK1MXks1Gltr4%3D 10.1016/S0002-9149(99)00258-1 10750587
15. BH Lorell BA Carabello 2000 Left ventricular hypertrophy: pathogenesis, detection, and prognosis Circulation 102 470 479 1:STN:280: DC%2BD3czptlKmug%3D%3D 10908222
16. J Nishizawa A Nakai M Komeda T Ban K Nagata 2002 Increased preload directly induces the activation of heat shock transcription factor 1 in the left ventricular overloaded heart Cardiovasc Res 55 341 348 1:CAS:528: DC%2BD38Xlt12ksLs%3D 10.1016/S0008-6363(02)00404-2 12123773 (Pubitemid 34775284)
17. K Obayashi M Horie LH Xie K Tsuchiya A Kubota H Ishida S Sasayama 1997 Angiotensin II inhibits protein kinase A-dependent chloride conductance in heart via pertussis toxin-sensitive G proteins Circulation 95 197 204 1:CAS:528:DyaK2sXnsV2htQ%3D%3D 8994437
18. K Paul NA Ball GW Dorn RA Walsh 1997 Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C epsilon isoform translocation in adult guinea pig hearts Circ Res 81 643 650 1:CAS:528:DyaK2sXntVyht70%3D 9351436
19. DS Reddy M Singh S Ghosh NK Ganguly 1996 Role of cardiac renin-angiotensin system in the development of pressure overload left ventricular hypertrophy in rats with abdominal aortic constriction Mol Cell Biochem 155 1 11 1:CAS:528:DyaK28XhtVCqtbY%3D 10.1007/BF00714327 8717433 (Pubitemid 26038061)
20. J Sadoshima Z Qiu JP Morgan S Izumo 1995 Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling Circ Res 76 1 15 1:CAS:528:DyaK2MXkt1SjsLo%3D 8001266
21. RE Schmieder MP Schlaich AU Klingbei 1P Martus 1998 Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996) Nephrol Dial Transplant 13 564 569 1:CAS:528:DyaK1cXit1OqsLc%3D 10.1093/ndt/13.3.564 9550628 (Pubitemid 28119033)
22. RS Vasan 2006 Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2335 2362 10.1161/CIRCULATIONAHA.104. 482570 16702488 (Pubitemid 43947980)
23. P Verdecchia 2005 Pre-clinical and clinical experience of telmisartan in cardiac remodelling J Int Med Res 33 Suppl 1 12A 20A 1:CAS:528: DC%2BD2MXhtFequ7jI 16222896
24. W Zhang 2002 Old and new tools to dissect calcineurin's role in pressure overload cardiac hypertrophy Cardiovasc Res 53 294 303 1:CAS:528: DC%2BD38XhtVKks74%3D 10.1016/S0008-6363(01)00451-5 11827679 (Pubitemid 34117679)
25. QG Zhang 2006 Hypertension and counter-hypertension mechanisms in giraffes Cardiovasc Hematol Disord Drug Targets 6 63 67 16724937
26. GQ Zhang W Zhang 2009 Heart rate, lifespan, and mortality risk Ageing Res Rev 8 52 60 10.1016/j.arr.2008.10.001 19022405
27. W Zhang RC Kowal F Rusnak RA Sikkink EN Olson RG Victor 1999 Failure of calcineurin inhibitors to prevent pressure overload left ventricular hypertrophy in rats Circ Res 84 722 728 1:CAS:528:DyaK1MXit1OisLo%3D 10189360
28. W Zhang BS Huang FH Leenen 1999 Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction Am J Physiol 276 H1608 H1615 1:CAS:528:DyaK1MXjsVWgs7Y%3D 10330245
29. GQ Zhang Z Zhu W Zhang 2009 Inhibitory effect of antihypertensive drugs on calcineurin in cardiomyocytes Am J Hypertens 22 132 136 1:CAS:528: DC%2BD1MXotVKisw%3D%3D 10.1038/ajh.2008.305 18927543
30. J Zhou X Xu JJ Liu YX Lin GD Gao 2007 Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes Clin Exp Pharmacol Physiol 34 1191 1198 1:CAS:528:DC%2BD2sXhtFyitrzI 10.1111/j.1440-1681.2007.04570.x 17880376 (Pubitemid 46148260)